BB Biotech (Switzerland) Today
| BION Stock | CHF 41.60 0.40 0.97% |
Performance0 of 100
| Odds Of DistressOver 64
|
BB Biotech is selling for under 41.60 as of the 24th of April 2024; that is 0.97 percent increase since the beginning of the trading day. The stock's lowest day price was 40.85. BB Biotech has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for BB Biotech AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of May 2022 and ending today, the 24th of April 2024. Click here to learn more.
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland. BB BIOTECH operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange.. The company has 54.99 M outstanding shares. More on BB Biotech AG
BION Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BB Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BB Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Biotechnology, Healthcare, Computing (View all Sectors) |
BB Biotech AG (BION) is traded on SIX Swiss Exchange in Switzerland and employs 10 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BB Biotech's market, we take the total number of its shares issued and multiply it by BB Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BB Biotech AG operates under Healthcare sector and is part of Biotechnology industry. The entity has 54.99 M outstanding shares.
BB Biotech AG has accumulated about 2.83 M in cash with (94.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 65.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BB Biotech Probability Of Bankruptcy
Ownership AllocationBB Biotech AG shows a total of 54.99 Million outstanding shares. Roughly 90.0 % of BB Biotech outstanding shares are held by general public with 1.7 percent owned by insiders and only 7.82 (percent) by institutions. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check BION Ownership Details
BION Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of BB Biotech jumping above the current price in 90 days from now is more than 93.0%. The BB Biotech AG probability density function shows the probability of BB Biotech stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon BB Biotech has a beta of 0.4211 suggesting as returns on the market go up, BB Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BB Biotech AG will be expected to be much smaller as well. Additionally, bB Biotech AG has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of BB Biotech to move above the current price in 90 days from now is more than 93.0 (This BB Biotech AG probability density function shows the probability of BION Stock to fall within a particular range of prices over 90 days) .
BB Biotech AG Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. BB Biotech market risk premium is the additional return an investor will receive from holding BB Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BB Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although BB Biotech's alpha and beta are two of the key measurements used to evaluate BB Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.07 | |||
| Semi Deviation | 1.25 | |||
| Standard Deviation | 1.36 | |||
| Variance | 1.86 |
BION Stock Against Markets
Picking the right benchmark for BB Biotech stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BB Biotech stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BB Biotech is critical whether you are bullish or bearish towards BB Biotech AG at a given time. Please also check how BB Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BB Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
How to buy BION Stock?
Before investing in BB Biotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in BB Biotech. To buy BB Biotech stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of BB Biotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase BB Biotech stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located BB Biotech AG stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased BB Biotech AG stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as BB Biotech AG, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in BB Biotech AG?
The danger of trading BB Biotech AG is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BB Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BB Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BB Biotech AG is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BB Biotech AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for BION Stock analysis
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets |